GREENBERG RICHARD S (EVP and Chairman) reported 1 transaction at NEXIEN BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/14/2020ACC: 0001214659-20-007221
DirectorOfficer10% Owner· EVP and Chairman
Since Jul 2018
+1.80M
Net shares
Net buyer
$25.2K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
1.80M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.80M
Price / share
$0.01
Trade value
$25.21K
% of position
202.8%
8/12/2020
888K→2.69M
Total
Net shares
+1.80M
Net value
$25.21K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/12/2020 | C · Conversion | +1.80M | $0.01 | $25.21K | 202.8% | 888K | 2.69M |
| Total | +1.80M | $25.21K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)0
No non-derivative holdings reported
Derivative Holdings (Post-Transaction)2
Options to purchase common stock (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
100K
Shares owned
100K
Exercise price
0.655
Expiration
—
Exercise window
—
Options to purchase common stock (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
150K
Shares owned
150K
Exercise price
0.54
Expiration
—
Exercise window
—
Total
Underlying
250K
Owned
250K
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Options to purchase common stock (right to buy) Direct | Common Stock | 0.655 | — | — | 100K | 100K |
| Options to purchase common stock (right to buy) Direct | Common Stock | 0.54 | — | — | 150K | 150K |
| Total | 250K | 250K | ||||